Floor Backes, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04781088) | Floor Backes, MD | 2021-09-01 |
| Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer (NCT04906382) | Floor Backes, MD | 2021-07-01 |
Track Floor Backes, MD automatically
Every clearance here is in the API, with alerts when new ones post.